Raymond James & Associates’s Accolade Inc ACCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$104K Buy
26,970
+778
+3% +$3.05K ﹤0.01% 3777
2024
Q2
$93.8K Buy
26,192
+267
+1% +$2.02K ﹤0.01% 3737
2024
Q1
$272K Buy
25,925
+202
+0.8% +$2.3K ﹤0.01% 3428
2023
Q4
$309K Hold
25,723
﹤0.01% 3263
2023
Q3
$272K Buy
+25,723
New +$338K ﹤0.01% 3274
2022
Q4
Sell
-14,341
Closed -$164K 4087
2022
Q3
$164K Sell
14,341
-7,785
-35% -$84.8K ﹤0.01% 3500
2022
Q2
$164K Buy
22,126
+1,974
+10% +$17.3K ﹤0.01% 3571
2022
Q1
$354K Sell
20,152
-44,766
-69% -$824K ﹤0.01% 3301
2021
Q4
$1.71M Sell
64,918
-3,820
-6% -$125K ﹤0.01% 2280
2021
Q3
$2.9M Buy
68,738
+1,185
+2% +$55.7K ﹤0.01% 1829
2021
Q2
$3.67M Buy
67,553
+34,560
+105% +$1.68M ﹤0.01% 1707
2021
Q1
$1.5M Buy
32,993
+2,303
+8% +$111K ﹤0.01% 2228
2020
Q4
$1.33M Buy
+30,690
New +$1.36M ﹤0.01% 2146

Other funds holding ACCD

Raymond James & Associates's ACCD Position: Q3 2024 in Review

Raymond James & Associates increased its Accolade Inc (ACCD) stake by 3% in Q3 2024, buying an estimated $3.05K and bringing the position to 26,970 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #3777.

Raymond James & Associates first reported a position in ACCD in Q4 2020 and has held it in 13 quarters since. The position peaked at $3.67M in Q2 2021. 150 funds tracked by Wall St. Rank hold ACCD as of Q3 2024.

  • Raymond James & Associates held 26,970 shares of Accolade Inc worth $104K as of Q3 2024.
  • Raymond James & Associates bought 778 Accolade Inc shares in Q3 2024, an estimated $3.05K.
  • Accolade Inc made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3777 holding.
  • Raymond James & Associates first reported a position in Accolade Inc in Q4 2020 and has held it in 13 quarters since.
  • Raymond James & Associates's Accolade Inc position peaked at $3.67M in Q2 2021.
  • 150 funds tracked by Wall St. Rank held Accolade Inc as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.